Your browser doesn't support javascript.
loading
The Czech Experience with Eculizumab in Severe Paediatric Shiga Toxin-Producing Escherichia coli-Associated Haemolytic Uremic Syndrome Patients.
Konopasek, Patrik; David, Jan; Marejkova, Monika; Simankova, Nadezda; Vondrak, Karel; Zieg, Jakub.
Affiliation
  • Konopasek P; Department of Pediatrics, Motol University Hospital, Praha, Czech Republic.
  • David J; Department of Pediatrics, Motol University Hospital, Praha, Czech Republic.
  • Marejkova M; National Reference Laboratory for E. coli and Shigellae, National Institute of Public Health, Praha, Czech Republic.
  • Simankova N; Department of Pediatrics, Motol University Hospital, Praha, Czech Republic.
  • Vondrak K; Department of Pediatrics, Motol University Hospital, Praha, Czech Republic.
  • Zieg J; Department of Pediatrics, Motol University Hospital, Praha, Czech Republic.
Klin Padiatr ; 234(1): 48-51, 2022 01.
Article in En | MEDLINE | ID: mdl-33167045
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli Infections / Shiga-Toxigenic Escherichia coli / Hemolytic-Uremic Syndrome Type of study: Risk_factors_studies Limits: Child / Humans Country/Region as subject: Europa Language: En Journal: Klin Padiatr Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli Infections / Shiga-Toxigenic Escherichia coli / Hemolytic-Uremic Syndrome Type of study: Risk_factors_studies Limits: Child / Humans Country/Region as subject: Europa Language: En Journal: Klin Padiatr Year: 2022 Document type: Article Affiliation country: